The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model
The neurotoxin 6-hydroxydopamine (6-OHDA) is widely used to induce models of Parkinson's disease (PD). We now know that the model induced by 6-OHDA does not include all PD symptoms, although it does reproduce the main cellular processes involved in PD, such as oxidative stress, neurodegeneratio...
Main Authors: | D. Hernandez-Baltazar, L.M. Zavala-Flores, A. Villanueva-Olivo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2017-10-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S217358081730113X |
Similar Items
-
The effect of voluntary exercise on MANF level in the brainstem of Parkinsonian rats induced by 6-Hydroxydopamine
by: Zia Fallah-mohammadi, et al.
Published: (2014-08-01) -
Synergistic Effects of Adenosine A2A Antagonist and L-DOPA on Rotational Behaviors in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Mouse Model
by: Takahiro Matsuya, et al.
Published: (2007-01-01) -
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP<sup>+</sup>) and 6-Hydroxydopamine (6-OHDA)
by: Marco Carli, et al.
Published: (2021-08-01) -
The possible role of cerium oxide (CeO2) nanoparticles in prevention of neurobehavioral and neurochemical changes in 6-hydroxydopamine-induced parkinsonian disease
by: Maha Abd Elkader Hegazy, et al.
Published: (2017-12-01) -
Pathophysiological signatures of functional connectomics in parkinsonian and dyskinetic striatal microcircuits
by: Jesús Pérez-Ortega, et al.
Published: (2016-07-01)